pharma · Mantle Cell Lymphoma · Colon cancer
Telethon Foundation
Fondazione Telethon ETS
Fondazione Telethon ETS is a pharma organization headquartered in EU. Primary therapeutic focus areas include Mantle Cell Lymphoma, Colon cancer, colorectal cancer, NSCLC non-small cell lung cancer, Follicular lymphoma.
Company details
- Status
- Public
- HQ
- roma, IT
- Founded
- 1990
- Employees
- 343
- Programs
- 162
- Drugs
- 285
- Patents
- 0
CAPTURE
Phase 2 · small molecule · Patients with advanced oncologic disease receiving active treatment with WHO level II or III opioids and adjuvants therapies
CAPTURE for Patients with advanced oncologic disease receiving active treatment with WHO level II or III opioids and adjuvants therapies is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Internal code CAPTURE
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Fondazione Telethon ETS
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Patients with advanced oncologic disease receiving active treatment with WHO level II or III opioids and adjuvants therapies
- Status
- active
- Trials
- 1